Suggested Learning

MHRA issues statement on halted French clinical trial

The Medicines and Healthcare products Regulatory Agency has issued a statement about the suspended phase one clinical trial trial carried out in France that left one person dead and four in hospital with neurological problems.

An MHRA spokesperson said:

  • "There is no clinical trial taking place in the UK with this product nor has it been used in a clinical trial in the UK in the past.
  • Clinical trials in general have an excellent safety record and hundreds of phase one clinical trials are authorised each year by MHRA.
  • Before any trial of a new medicine begins in humans, the product will have undergone extensive pre-clinical testing, both in the laboratory and in animals as appropriate.
  • Safeguards for clinical trials are well-established and regulations are in place, which specifies how clinical trials should be conducted."

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Independent Pharmacist's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.